News

Oil Fluctuates as Israel-Iran Conflict Fuels Market Volatility Oil prices were volatile in Asian trading Tuesday, as markets weighed the odds of a resolution to the Israel-Iran conflict against the ...
Oil Climbs Over 2% on Middle East Risks -- Market Talk ...
Zealand Pharma A/S posted the largest decline among large stocks during the session, falling 9.2%, followed by Norbit ASA shares, which dropped 4.6%. Shares of Bakkafrost P/F declined 4.3%.
The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...
While the Senate proposal would eventually remove credits provided by the Biden administration's Inflation Reduction Act, analysts at J.P. Morgan and Mizuho said the Senate version is better for ...
Exxon Mobil Corporation (XOM) is currently at $113.87, up $1.39 or 1.24% --Would be highest close since April 2, 2025, when it closed at $118.67 --Currently up eight consecutive days; up 11.82% over ...
More builders were also offering other types of discounts. The use of sales incentives was 62%, up from last month's 61%. These include mortgage-rate buydowns, where the builder offers a lower ...
"Canola is still a rocket ship," the analyst said. He added that if the rain does fall over the region on the weekend, "it would be a drink just at the right time." As well for canola, there were ...
As a result, restaurant spending generally will rise and set fresh records every year. The increase could reflect an ever-growing population, higher prices due to inflation or a long-term trend in ...
The United States Department of Justice Cell Phone Service Provider Agrees to Pay $500,000 for Imposing Unlawful Charges on Military Servicemembers ...
Given the number of threats on the horizon, investors who ascribe to the "nothing ever happens" philosophy risk becoming complacent, Cox said. Still, as history has shown, even when there is a bear ...
Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run. Fresenius' balance sheet remains manageable, ...